FORM 8-K

Company

Cellectar Biosciences, Inc.

Filed

October 10, 2025

Period of Report

October 7, 2025

Accession Number

0001104659-25-098725

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →